S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Breaches by Iran-affiliated hackers spanned multiple U.S. states, federal agencies say
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
A man fatally stabbed 4 family members before police shot and killed him; 2 officers injured
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Lacking counselors, US schools turn to the booming business of online therapy
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Breaches by Iran-affiliated hackers spanned multiple U.S. states, federal agencies say
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
A man fatally stabbed 4 family members before police shot and killed him; 2 officers injured
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Lacking counselors, US schools turn to the booming business of online therapy
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Breaches by Iran-affiliated hackers spanned multiple U.S. states, federal agencies say
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
A man fatally stabbed 4 family members before police shot and killed him; 2 officers injured
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Lacking counselors, US schools turn to the booming business of online therapy
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Breaches by Iran-affiliated hackers spanned multiple U.S. states, federal agencies say
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
A man fatally stabbed 4 family members before police shot and killed him; 2 officers injured
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Lacking counselors, US schools turn to the booming business of online therapy

Creative Medical Technology Stock Price, News & Analysis (NASDAQ:CELZ)

$4.57
+0.12 (+2.70%)
(As of 12/1/2023 ET)
Compare
Today's Range
$4.37
▼
$4.57
50-Day Range
$4.22
▼
$5.45
52-Week Range
$3.46
▼
$14.20
Volume
1,603 shs
Average Volume
5,438 shs
Market Capitalization
$6.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Creative Medical Technology MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
2.67% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.29mentions of Creative Medical Technology in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($3.68) to ($4.62) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.53 out of 5 stars

See Top Rated MarketRank™ Stocks Here

CELZ stock logo

About Creative Medical Technology Stock (NASDAQ:CELZ)

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

CELZ Stock Price History

CELZ Stock News Headlines

November 26, 2023 | americanbankingnews.com
Head-To-Head Contrast: Creative Medical Technology (CELZ) & The Competition
October 11, 2023 | msn.com
Creative Medical to initiate trial of lower back pain treatment
December 3, 2023 | Wealthpress (Ad)
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
October 10, 2023 | markets.businessinsider.com
Creative Medical Gets IRB Approval For StemSpine Trial Using AlloStem Cell Therapy
October 10, 2023 | finance.yahoo.com
Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain
September 22, 2023 | finance.yahoo.com
What Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy Stock
September 19, 2023 | finance.yahoo.com
Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain
August 24, 2023 | finance.yahoo.com
What Is Allogeneic Cell Therapy, And What’s Driving This Market’s 25%+ Annual Global Growth?
December 3, 2023 | DTI Trader (Ad)
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
August 23, 2023 | benzinga.com
What Is Allogeneic Cell Therapy, And What's Driving This Market's 25%+ Annual Global Growth?
June 28, 2023 | msn.com
Creative Medical Technology regains Nasdaq listing compliance
June 12, 2023 | finance.yahoo.com
Creative Medical Technology Holdings Provides Corporate Update
June 12, 2023 | finance.yahoo.com
Creative Medical Technology Announces $2 Million Share Repurchase Program
June 9, 2023 | msn.com
Creative Medical Technology Holdings announces reverse stock split to regain compliance
May 31, 2023 | finance.yahoo.com
Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy Platform
May 18, 2023 | msn.com
Creative Medical Releases Data From StemSpine Procedure For Chronic Lower Back Pain
May 18, 2023 | finance.yahoo.com
Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Line
May 14, 2023 | finance.yahoo.com
Creative Medical Technology Holdings First Quarter 2023 Earnings: US$0.075 loss per share (vs US$0.18 loss in 1Q 2022)
April 13, 2023 | msn.com
Creative Medical (CELZ) Up 86% on Upbeat Diabetes Study Data
April 12, 2023 | msn.com
Creative Medical Technology Soars after Positive Drug Data
April 12, 2023 | benzinga.com
Thinking about buying stock in Newmark Group, Exscientia, Pardes Biosciences, Creative Medical Technology, or Somalogic?
April 12, 2023 | msn.com
Why Is Creative Medical Technology Stock Skyrocketing Today?
April 4, 2023 | finance.yahoo.com
Creative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business Update
March 23, 2023 | msn.com
Creative Medical stock rises on seeking FDA orphan drug status for Brittle diabetes therapy
March 23, 2023 | finance.yahoo.com
Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 Diabetes
March 21, 2023 | finance.yahoo.com
Creative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform Development
March 7, 2023 | finance.yahoo.com
Creative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201
See More Headlines
Receive CELZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creative Medical Technology and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/03/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/29/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CELZ
CUSIP
N/A
CIK
1187953
Web
www.creativemedicaltechnology.com
Phone
(833) 336-7636
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($7.80)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,140,000.00
Net Margins
N/A
Pretax Margin
-39,296.00%
Return on Equity
-69.54%
Return on Assets
-64.36%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
28.61
Quick Ratio
28.59

Sales & Book Value

Annual Sales
$90,000.00
Price / Sales
70.07
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.75 per share
Price / Book
0.52

Miscellaneous

Outstanding Shares
1,380,000
Free Float
1,336,000
Market Cap
$6.31 million
Optionable
Not Optionable
Beta
2.25
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report














CELZ Stock Analysis - Frequently Asked Questions

How have CELZ shares performed in 2023?

Creative Medical Technology's stock was trading at $3.8110 on January 1st, 2023. Since then, CELZ shares have increased by 19.9% and is now trading at $4.57.
View the best growth stocks for 2023 here.

Are investors shorting Creative Medical Technology?

Creative Medical Technology saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 36,100 shares, a decline of 5.7% from the October 31st total of 38,300 shares. Based on an average daily trading volume, of 27,700 shares, the days-to-cover ratio is currently 1.3 days. Approximately 2.7% of the shares of the company are short sold.
View Creative Medical Technology's Short Interest.

When is Creative Medical Technology's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our CELZ earnings forecast.

When did Creative Medical Technology's stock split?

Shares of Creative Medical Technology reverse split on the morning of Sunday, June 11th 2023. The 1-10 reverse split was announced on Sunday, June 11th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, June 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Creative Medical Technology?

Shares of CELZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:CELZ) was last updated on 12/3/2023 by MarketBeat.com Staff

My Account -